Bridgepoint Group (LON:BPT) Shares Down 9.6% – Here’s What Happened

Bridgepoint Group plc (LON:BPT)’s stock price dropped 9.6% during trading on Wednesday . The company traded as low as GBX 240.60 and last traded at GBX 240.80. Approximately 6,589,081 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 8,079,381 shares. The stock had previously closed at GBX 266.40.

Analyst Upgrades and Downgrades

Separately, Citigroup dropped their price objective on shares of Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Bridgepoint Group presently has an average rating of “Moderate Buy” and a consensus price target of GBX 385.

Bridgepoint Group Stock Performance

The business’s 50 day moving average is GBX 253.15 and its 200 day moving average is GBX 264.63. The company has a current ratio of 279.03, a quick ratio of 3.60 and a debt-to-equity ratio of 55.04. The stock has a market capitalization of £2.10 billion, a PE ratio of 49.02, a PEG ratio of 0.61 and a beta of 1.36.

Bridgepoint Group (LON:BPT) last posted its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 earnings per share (EPS) for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. On average, equities research analysts predict that Bridgepoint Group plc will post 17.4062165 earnings per share for the current fiscal year.

Insider Transactions at Bridgepoint Group

In other news, insider Michelle Scrimgeour bought 21,616 shares of the stock in a transaction on Thursday, March 12th. The stock was acquired at an average cost of GBX 230 per share, for a total transaction of £49,716.80. 0.60% of the stock is currently owned by company insiders.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.